No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty

摘要

Background and purpose We have previously shown that during the first 2 years after total hip arthroplasty (THA), periprosthetic bone resorption can be prevented by 6 months of risedronate therapy. This follow-up study investigated this effect at 4 years.